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Cascade reactions integrate two or more reactions, of which each subsequent reaction
can only start when the previous reaction step is completed. Employing natural
substrates in the human body such as glucose and oxygen, cascade reactions can
generate reactive oxygen species (ROS) to kill tumor cells, but cascade reactions may
also have potential as a direly needed, novel bacterial infection-control strategy. ROS can
disintegrate the EPS matrix of infectious biofilm, disrupt bacterial cell membranes, and
damage intra-cellular DNA. Application of cascade reactions producing ROS as a new
infection-control strategy is still in its infancy. The main advantages for infection-control
cascade reactions include the fact that they are non-antibiotic based and induction
of ROS resistance is unlikely. However, the amount of ROS generated is generally
low and antimicrobial efficacies reported are still far <3–4 log units necessary for
clinical efficacy. Increasing the amounts of ROS generated by adding more substrate
bears the risk of collateral damage to tissue surrounding an infection site. Collateral
tissue damage upon increasing substrate concentrations may be prevented by locally
increasing substrate concentrations, for instance, using smart nanocarriers. Smart,
pH-responsive nanocarriers can self-target and accumulate in infectious biofilms from the
blood circulation to confine ROS production inside the biofilm to yield long-term presence
of ROS, despite the short lifetime (nanoseconds) of individual ROS molecules. Increasing
bacterial killing efficacies using cascade reaction components containing nanocarriers
constitutes a first, major challenge in the development of infection-control cascade
reactions. Nevertheless, their use in combination with clinical antibiotic treatment may
already yield synergistic effects, but this remains to be established for cascade reactions.
Furthermore, specific patient groups possessing elevated levels of endogenous substrate
(for instance, diabetic or cancer patients) may benefit from the use of cascade reaction
components containing nanocarriers.
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INTRODUCTION
Bacterial infections have threatened mankind ever since its first
existence. Infection control gained a major success with the
discovery of antibiotics in 1923. However, this success lasted
less than a century, and toward the turn of the century, the
first reports of antibiotic-resistant bacterial pathogens appeared
(Davies and Davies, 2010). The latest new antibiotic class was
discovered in 1986, after which shortening of the effective lifetime
of new antibiotics, and financial and regulatory hurdles cooled
down the passion of pharmaceutical companies to develop new
antibiotics. It is estimated that the number of deaths attributable
to antimicrobial-resistant bacterial infections will rise to 10
million per year by 2050, at a cost of more than US$100 trillion
(O’Neill, 2014).
An additional problem in infection control, next to antibiotic
resistance, is the presentation of infectious bacteria in a biofilm
mode of growth. In a biofilm mode of growth, adhering bacteria
produce a matrix of extracellular polymeric substances (EPS), in
which they protect themselves against the host immune system
and environmental attacks, such as posed by UV exposure, pH
changes, and antibiotics (Hall-Stoodley et al., 2004). The EPS
matrix impedes penetration of antibiotics, yielding survival of
bacteria residing in the depth of a biofilm, which necessitates
long-term and high-dose antimicrobial treatment to eradicate
infectious biofilms, not seldom followed by recurrence of the
infection after treatment (Fux et al., 2005).
To counter the increasing threat of bacterial infections,
numerous nanotechnology-based antimicrobials and smart,
antimicrobial-delivery nanocarriers are being designed (Liu et al.,
2019a), such as carbon quantum dots, graphene, gold, silver,
iron oxide, or polymeric nanoparticles, including micelles or
antimicrobial dendrimers. However, the antimicrobial efficacy
of many new nanoparticles are insignificant for clinical usage
and only achieve about 90% reductions in bacterial viability
(1 log unit), while a minimum of 99.9–99.99% (3–4 log units)
is required to achieve any clinical efficacy (Liu X. et al., 2019).
ROS are sometimes called “the sword of nanotechnology,” and
taking lessons from cancer therapy, several methods have become
available to generate ROS (Sun et al., 2014; Liu X. et al., 2019).
ROS produced by different types of nanoparticles in combination
with the addition of external H2O2 (Gao et al., 2016; Liu et al.,
2018; Naha et al., 2019) has been shown to be effective in biofilm
eradication. However, the use of cascade reactions to counter
bacterial infections through ROS production using endogenously
present substrate, i.e., without addition of external H2O2, has not
yet been extensively considered.
A cascade reaction, also called tandem or domino reaction,
is a chemical process that integrates at least two reactions, of
which each subsequent reaction can only start when the previous
reaction step is completed (Ricca et al., 2011). Enzymatic
cascade reactions combine a series of enzymatic substrate
transformations to produce a final product. In liner cascade
reactions, the product of the first enzymatic reaction becomes
the substrate of a second reaction (Ricca et al., 2011). Enzymatic
cascade reactions widely occur in living organisms (Ricca et al.,
2011). Photosynthesis and aerobic respiration, for instance,
are enzymatic cascade reactions producing carbohydrates and
carbon dioxide, respectively. Industrially, enzymatic cascade
reactions are used in the one-pot synthesis of chemicals.
Liner cascade reactions are the most widely used type of
cascade reaction in cancer and infection therapy. Using naturally
occurring substrates in the human body such as endogenous
glucose and oxygen, cascade reactions can be used to produce
highly toxic ROS (Figure 1A) (Yan et al., 2018), as an anti-cancer
drug (Li et al., 2017) or antimicrobial (André et al., 2011; Liu et al.,
2017; Liu X. et al., 2019) (Figure 1B).
In this review, we will focus on recent progress in the design
of cascade reactions as a new strategy in infection control,
taking lessons from current developments aimed toward using
cascade reactions in cancer therapy. Use of cascade reactions for
infection control is slowly emerging, yet offering equal or more
perspective than new antibiotics or non-ROS-based infection-
control strategies, because hitherto bacterial resistance to ROS
has not been reported and is generally considered highly unlikely
to develop.
CHEMISTRY OF CASCADE REACTIONS
In this section, different kinds of cascade reactions are classified
by substrate. The conditions and mechanisms to achieve these
cascade reactions are summarized.
Glucose and Oxygen
Glucose is the most important carbohydrate in the human body
and can yield gluconic acid and H2O2 upon reaction with oxygen
(Itskov and Carlos, 2013; Fan et al., 2017), according to
Glucose+O2 → Gluconicacid+H2O2 (1)
The production of H2O2 according to reaction (1) can be
catalyzed by glucose oxidase (GOx), as the first reaction in a
liner cascade reaction (Figure 1A). This catalytic process can be
divided into a reductive and oxidative half-reaction, as shown
in Figure 2A. In the reductive half-reaction, β-D-glucose loses
two electrons to form δ-gluconolactone, which is subsequently
hydrolyzed to gluconic acid. After receiving two electrons from
the reductive half-reaction, the flavin ring of GOx becomes
reduced to FADH2 after which, in the oxidative half-reaction,
the same two electrons transferred from GOx-FADH2 to oxygen
yield H2O2 and GOx in an oxidized state (Witt et al., 2000).
Reaction (1) can also be catalyzed by gold nanoparticles and
modified graphitic carbon nitride, as shown schematically in
Figures 2B,C, respectively.
In the second reaction of the cascade, different artificial,
catalytic nanoparticles can be employed to transform H2O2 into
·OH, 1O2 (singlet oxygen), and ·O
−
2 (Cho et al., 2019). These
catalytic nanoparticles include AuNPs (Zhang et al., 2019), iron
oxide (Fan et al., 2012; Duan et al., 2015; Gao et al., 2016; Liu
et al., 2018; Naha et al., 2019), silver halides (Wang et al., 2014),
platinum (Liu X. et al., 2016; Wu et al., 2018), cerium oxide
(Niu et al., 2007; Celardo et al., 2011), vanadium oxide (André
et al., 2011), 2D metallo-porphyrinic metal-organic framework
(MOF) nanosheets (Huang et al., 2017), and molybdenum
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FIGURE 1 | Schematics of cascade reactions for combating infectious biofilms. (A) Different substrates and enzymes involved in substrate transformations to
generate different types of ROS. (B) ROS can combat infectious biofilms by degrading the EPS matrix of an infectious biofilm (Yan et al., 2018), disrupting bacterial cell
membranes (Wang et al., 2017), and damaging intra-cellular DNA of biofilm inhabitants (Rowe et al., 2008; Cadet and Wagner, 2013).
Frontiers in Chemistry | www.frontiersin.org 3 January 2020 | Volume 7 | Article 861
Li et al. Cascade Reactions in Bacterial Infection-Control
FIGURE 2 | Substrate transformations in cascade reactions generating ROS, based on glucose and oxygen as substrates. (A) Generation of H2O2 from glucose
using GOx (Witt et al., 2000) (with permission of Portland Press). (B) Catalysis of glucose transformation to H2O2 using catalytic, gold nanoparticles (Comotti et al.,
2006) (with permission of John Wiley and Sons). (C) Modified carbon nitride as a bifunctional glucose-peroxidase enzyme-mimic (Zhang et al., 2019) (with permission
of Nature Publishing Group). (D) Activation of H2O2 on Fe3O4 nanoparticles to achieve transformation of H2O2 to ROS (Wang et al., 2010) (with permission of
Elsevier). (E) V2O5 nanowires catalyze transformation of H2O2 to ·O
−
2 in the presence of ABTS [2,2
′-azinobis(3-ethylbenzthiazoline-6-sulfonate)] (André et al., 2011)
(with permission of John Wiley and Sons).
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FIGURE 3 | The mechanism of NO generation through reaction between L-arginine and H2O2 (Fan et al., 2017).
disulfide (MoS2) nanoflowers (Yin et al., 2016). Metal-free
artificial catalysts include modified carbon nitride (Yin et al.,
2016), graphene oxide (Song et al., 2010), and graphene quantum
dots (Sun et al., 2014; Duan et al., 2015). Importantly, these
catalytic nanoparticles can be functionally modified to enhance
their catalytic activity. However, mechanisms to transform H2O2
into ·OH, 1O2, and ·O
−
2 are different for different artificial
catalytic nanoparticles. Proposed catalytic mechanisms for iron
oxide nanoparticles and V2O5 nanowires are summarized in
Figures 2D,E (Natalio et al., 2012). Light irradiation can also be
used as a catalytic mediator to split H2O2 into two ·OH (Chang
et al., 2017).
Glucose and L-arginine
In another cascade reaction involving glucose (Figure 1A),
L-arginine can be employed to produce highly toxic nitric oxide
(NO) by oxidation of the guanidine function of L-arginine (see
also Figure 3). Interestingly, gluconic acid, as a by-product in
reaction (1), leads to a pH decrease, accelerating L-arginine
catalytic transformation of H2O2 into NO (Fan et al., 2017).
H2O2
H2O2 can also act as a substrate for generating
1O2 in cascade
reactions, as catalyzed in the first cascade reaction by catalase,
a tetrameric heme protein (Figure 4A) (Alfonso-Prieto et al.,
2009) or artificial, catalytic nanoparticles, such as cerium oxide
nanoparticles (Figure 4B) (Herget et al., 2017). In the second
reaction, also light can be used to transform O2 into singlet
oxygen, which requires the presence of a suitable photosensitizer
(Li et al., 2017), such as tetrapyrroles (absorption band around
400 nm), porphyrins (absorption band around 630 nm), chlorins
(absorption band around 650–690 nm), or “bacteriochlorins”
with an absorption band shifted further into the red (Castano
et al., 2004).
H2O2 and halides
In the presence of H2O2 and halides X
− [such as chloride (Cl−)
or bromide (Br−) ions], vanadium peroxidase (see Figure 5A),
V2O5 nanowires (Natalio et al., 2012) (Figure 5B), and CeO2−x
nanorods (Herget et al., 2017) (Figure 5C) can also be used in the




+H+ → H2O+HOX (2)
HOX+H2O2 →





An H2O2-free cascade reaction is based on water (H2O) and
calcium peroxide (CaO2), as substrates (Figure 1A) according to
Yan et al. (2018)
CaO2 + 2H2O→ H2O2 + Ca(OH)2 (4)
CaO2 reacts with H2O through a redox reaction, in which
CaO2 as a reducing agent loses four electrons. After obtaining
the corresponding electrons, H2O is oxidized to H2O2 after
which, in the second reaction of the cascade, H2O2 can
be transformed into ·OH, 1O2 and ·O
−
2 by any of the
reactions described in sections Glucose and Oxygen and Glucose
and L-Arginine.
APPLICATION OF CASCADE REACTIONS
IN CANCER THERAPY
The main substrates and enzymes in cascade reactions producing
ROS that are currently considered for anti-tumor therapy involve
glucose and oxygen, glucose and L-arginine, or H2O2/Cl
−
as substrates (Figure 6). GOx and Fe3O4 nanoparticles have
been contained into dendritic silica nanocarriers to initiate a
cascade reaction, using endogenous glucose present in tumor
cells to generate H2O2 (Huo et al., 2017). As a second step,
the Fe3O4 nanoparticles catalyze H2O2 into highly toxic ·OH.
In vivo, this cascade reaction demonstrated suppression of
mammary tumor growth. Instead of using GOx and Fe3O4
nanoparticles in dendritic silica to produce ROS (hydroxyl
radicals), GOx and catalase have also been integrated in
MOF nanocarriers (Li et al., 2017). Here, as the second step
in the cascade reaction, H2O2 produced endogenously or
from oxidation of glucose by GOx, is converted to oxygen
by catalase. After that, singlet oxygen (1O2) is generated
under 660-nm light irradiation (Li et al., 2017). Alternatively,
another cascade reaction involving photodynamics based on
one enzyme was described (Chang et al., 2017), in which GOx
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FIGURE 4 | Proposed mechanisms of enzymatic transformations using H2O2 as a substrate. (A) Transformation of H2O2 by catalase into O2 (Alfonso-Prieto et al.,
2009). (B) Transformation of H2O2 using catalytic cerium oxide nanoparticles (“nanoceria”) into O2 (Celardo et al., 2011) (with permission of the Royal Society of
Chemistry).
was conjugated to polymer dots to convert glucose into H2O2.
Under light irradiation, the H2O2 generated was photolyzed to
hydroxyl radicals.
Glucose and L-arginine have also been used as substrates
in cascade reactions to produce NO (see also Figure 6) in
order to kill tumor cells (Fan et al., 2017). To this end, GOx
and L-arginine have been contained in hollow, mesoporous
organosilica nanocarriers, and after generation of H2O2 from
glucose present in tumor sites using GOx, reaction of H2O2 with
L-arginine generated NO, which was shown to prolong the life of
tumor-bearing mice.
Finally, endogenous ·O−2 and Cl
− have been used as substrates
in cascade reactions (Wang et al., 2014). Using superoxide
dismutase (SOD) and chloroperoxidase (CPO), endogenous ·O−2
can be catalyzed by SOD to H2O2, which is subsequently further
oxidized with the aid of Cl− and CPO to 1O2. This cascade
reaction showed negligible toxicity to healthy cells, but was highly
toxic to tumor cells.
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FIGURE 5 | Proposed mechanisms of enzymatic transformations using H2O2 and halides as substrates. (A) Transformation of H2O2 and halides by vanadium
peroxidase (Ligtenbarg et al., 2003) (with permission of Elsevier). (B) Transformation of H2O2 and halides by V2O5 nanowires (Natalio et al., 2012) (with permission of
Nature Publishing Group). (C) CeO2−x nanorod as catalase (Herget et al., 2017) (with permission of John Wiley and Sons).
APPLICATION OF CASCADE REACTIONS
FOR BACTERIAL INFECTION CONTROL:
LESSONS FROM TUMOR TREATMENT
Based on the similarity between tumor sites and bacterial
biofilms (Table 1), we can take lessons from the cascade reactions
considered for tumor therapy, as shown in Figure 6. All
endogenous substrates used for cancer therapy are available in
bacterial infection sites, and ROS shows highly toxic toward
all bacterial pathogens, regardless of their Gram character
(Vatansever et al., 2013). Therefore, cascade reactions are
nowadays started to be considered as an alternative strategy
for the control of infectious biofilms. The number of studies
applying cascade reaction for bacterial infection control is
limited however (see overview in Table 2), but their results
warrant analysis and offer future perspective that are new for
infection control.
Cascade Reactions Considered for
Bacterial Infection Control
Application of cascade reactions as a new infection-control
strategy is currently in its infancy, and to our knowledge, only
four studies so far have considered the use of cascade reactions for
infection control (see Table 2) that employ different nanocarriers
for the cascade reaction components.
Two cascade reactions based on glucose and O2 as substrate
have been evaluated for their antimicrobial activity. GOx
absorbed in ultrathin two-dimensional (2D) MOF nanosheet
carriers (Liu X. et al., 2019), in vitro generated ROS that
killed planktonic Escherichia coli and Staphylococcus aureus
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FIGURE 6 | Different cascade reactions considered for tumor treatment, using glucose, O2, H2O2, and Cl
− (endogenously available) and L-arginine (not
endogenously available) as substrates, yielding different types of ROS.
TABLE 1 | Similarities between tumor sites and infectious biofilms, stimulating the application of cascade reactions in infectious bacterial biofilms, taking lessons from
their application in tumor treatment.
Similarity Tumor site Infectious biofilm
Hampered transport Tumors larger than 2 mm3, limit oxygen diffusion
(Trédan et al., 2007; Danhier et al., 2010).
The EPS matrix limits transport of nutrients to the depth of
a biofilm (Flemming et al., 2007; Billings et al., 2015).
Acidic pH Acidic pH between 6.0 and 7.0 (Justus et al., 2013). Acidic pH < 6.0 (Koo et al., 2017; Liu et al., 2019a).
Endogenous substrate
availability
High killing efficacy of ROS toward tumor cells
(Postiglione et al., 2011).
ROS can destruct the EPS matrix and kill biofilm bacteria
(Walch et al., 2015).
Clinical treatment Occurrence of resistance against chemotherapeutics,
recurrence of tumor growth (Mansoori et al., 2017).
Occurrence of resistance against antimicrobials,
recurrence of infection (Aslam et al., 2018).
after 5 h incubation with 15mM glucose in the growth
medium. Bacterial killing was far lower (88 and 90% for
E. coli and S. aureus, respectively) than the 99.9–99.99%
efficacy limit considered to be required for clinical efficacy
(Liu et al., 2019a). However, when locally applied as a 2D
MOF/GOx band-aid on infected (3 × 107 CFU/site S. aureus)
wounds in mice, mice treated with 2D MOF/GOx band-aids
containing 50 µl of a 10mM glucose solution showed faster
wound healing after 3 days of treatment, retrieving less (91%
reduction) CFUs than when treated with blank band-aids.
Glucose and O2 were also used as substrates in combination
with another peroxidase, hemoglobin (Hb) to catalyze H2O2
into ·OH. Cascade reaction components were contained in
MnCO3 nanocarriers (Li et al., 2019). In growth medium
supplemented with glucose to a concentration of 12.5mM,
i.e., substantially higher than endogenously occurring (before
eating <6.1mM; Stumvoll et al., 2005), GOx-Hb nanocarriers
yielded 7 log unit inhibition in planktonic MRSA growth
(Figure 7). In addition, biomass analysis based on Crystal
Violet staining indicated the ability of GOx-Hb nanocarriers
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TABLE 2 | Summary of cascade reactions considered for infection control, including substrates required, nanocarriers of cascade reaction components, types of ROS
generated, and antimicrobial activities observed.
Substrate Nanocarrier ROS Antimicrobial activity References
Glucose/Oxygen
·OH - Against planktonic S. aureus and E. coli
- Improved infected wound healing
in mice
Liu X. et al.,
2019
·OH - Against planktonic MRSA
- Inhibiting MRSA biofilm formation
Li et al., 2019
CaO2/H2O ·OH - Against planktonic S. aureus and E. coli
- Inhibiting S. aureus biofilm formation
- Dispersing S. aureus biofilm





− 1O2 - Against planktonic S. aureus and E. coli
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FIGURE 7 | CFUs (MRSA) in growth medium supplemented with glucose
(12.5mM) after 24 h of growth, as a function of GOx-Hb nanocarrier
concentration. For control, nanocarriers with denatured GOx (dGOx-Hb) were
included (Li et al., 2019) (with permission of ACS).
to inhibit MRSA biofilm formation during 48 h exposure
to GOx-Hb and incubation in glucose supplemented growth
medium. Nanocarriers containing denatured GOx did not inhibit
biofilm formation.
A cascade reaction using CaO2 and H2O as substrates to
generate hydroxyl radicals was fabricated by containing CaO2
and hemin-carrying graphene into alginate (Yan et al., 2018).
Importantly, these alginate nanocarriers did not contain any
H2O2 as a substrate and CaO2 and H2O were locally converted
into ROS. Planktonically, these nanocarriers yielded relatively
low killing of S. aureus and E. coli (90 and 95%, respectively, after
6 h exposure). Also, 72-h S. aureus biofilm growth in the presence
of the cascade reaction components containing nanocarriers was
low, yielding<5-µm-thick biofilms vs. 25µm in their absence. In
addition, exposure of an existing S. aureus biofilm to the cascade
reaction components containing nanocarriers eradicated 81% of
its inhabitants. Interestingly, these cascade reaction components
containing nanocarriers caused biofilm dispersal, degrading
DNA and proteins, as major components of the EPS-matrix
holding a biofilm together. Finally, S. aureus-infected wounds (1
× 105 CFU/site) in rats gradually healed after 7 days (>90%
bacterial killing) when treated with these alginate nanocarriers,
with obvious swelling and pus formation in control groups.
H2O2 has also been used in combination with Br
− as
substrates in the presence of V2O5 nanowires, with an intended,
initial use in the marine environment (Natalio et al., 2012). V2O5
nanowires can work as natural haloperoxidases to transform
bromide ions to hypobromous acid (HOBr) in the presence of
H2O2 (Natalio et al., 2012). The antimicrobial activity against
human pathogens was low, however, decreasing planktonic
growth of E. coli by only 78% and of S. aureus by only 96% in
the presence of V2O5 nanowires (0.075 mg/ml), Br2 (1mM), and
H2O2 (10µM), and as compared to bacteria grown in the absence
of additives.
Advantages and Disadvantages of
Cascade Reactions for Biofilm Control
The main advantages for infection-control cascade reactions
include the fact that they are non-antibiotic based. Bacteria
possess little or no resistance against ROS, although some
bacterial species can develop resistance against specific ROS
species, such as ·O−2 and H2O2, but not against
·OH and 1O2
(Vatansever et al., 2013). Often, however, different species of
ROS are generated at the same time in catalytic reactions. ROS
as generated in cascade reactions kills both Gram-positive and
Gram-negative bacterial strains in a non-specific way. On the
one hand, this may be considered an advantage, but on the
other hand, the commensal microflora can also be affected,
unless the cascade reaction can be localized in or near the
infection site. Although nanocarriers and artificial enzymes
used in cascade reactions are relatively easy to synthesize and
modify, confining ROS generation to an infection site may be
more troublesome.
As a drawback of the current status of cascade reactions, the
amount of ROS generated is generally low and antimicrobial
efficacies reported are below the limit of 3–4 log units considered
necessary for clinical efficacy (Yan et al., 2018; Liu et al., 2019a).
Although the amount of ROS generated can be enhanced by
adding more substrate (Fan et al., 2017), this needs to be
done carefully in order to prevent collateral damage to tissue
surrounding an infection site. This, too, requires confining of
ROS generation to an infection site.
PERSPECTIVES OF THE USE OF CASCADE
REACTIONS FOR INFECTION CONTROL
The antimicrobial activity of ROS (Rowe et al., 2008; Cadet
and Wagner, 2013; Vatansever et al., 2013; Gao et al., 2016;
Wang et al., 2017; Liu et al., 2018; Yan et al., 2018) and the
potential advantages of the use of cascade reaction as a new
infection-control strategy warrant their further development for
infection control, but several challenges have to be overcome
before their clinical use becomes into sight. The biggest
challenge in the further development of infection-control cascade
reactions is to increase their bacterial killing efficacy to levels
that can be expected to be clinically effective (i.e., minimally
3–log unit reductions in CFUs, equal to minimal percentage
reductions of 99.9–99.99%). This should preferentially be done
using endogenously available substrates, but this option should
be carefully balanced against the potential damage that high
concentrations of ROS can do to tissue cells surrounding an
infection site (Li et al., 2019). Alternatively, additional substrate
can be locally administered to increase local ROS generation,
which may reduce collateral tissue damage. Collateral tissue
cell damage might be fully prevented by using self-targeting,
pH-responsive nanocarriers that penetrate and accumulate in
infectious biofilms (Liu Y. et al., 2016), to confine the occurrence
of the cascade reaction and generation of ROS to inside the
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biofilm itself. A further advantage of such confinement would
be that it will create long-term presence of ROS in a biofilm to
enhance bacterial killing, despite the short lifetime (nanoseconds)
of individual ROS molecules, arguably too short to yield effective
bacterial killing.
Nevertheless, cascade reactions generating relatively low levels
of ROS might still be clinically useful in combination with
clinically applied antibiotics to enhance their fading efficacies
(Nguyen et al., 2016). Synergistic action between different
antimicrobials is a common phenomenon, and it is known
to even yield killing of bacterial pathogens that are resistant
to either of the antimicrobials when applied in monotherapy
(Klahn and Brönstrup, 2017). This approach bears advantages
for downward clinical translation of infection-control cascade
reactions, because it builds on existing clinically applied
antibiotics, from which further development of infection-control
cascade reactions can be facilitated more easily. Moreover,
it might increase the effective lifetime of current and new
antibiotics to be developed (Liu et al., 2019b), with the potential
to reduce the induction of antibiotic resistance (Mao et al., 2018).
As a final perspective of infection-control cascade reactions,
specific patient groups with elevated endogenous substrate
levels may benefit from cascade reactions. Diabetic patients,
for instance, can suffer from difficult-to-heal infected wounds
and have elevated glucose levels (ranging from ≥7.0mM before
to ≥11.1mM after eating) compared with healthy glucose
levels (ranging from <5.6mM before to 7.8mM after eating)
(Stumvoll et al., 2005). Local generation of ROS through suitable
cascade reactions may be extremely suitable for treating diabetic
foot ulcers that have been demonstrated to be caused by
hard-to-treat infectious biofilms (Neut et al., 2011). Cancer
patients are another specific patient group for which infection-
control cascade reactions could be useful. There is growing
evidence that bacteria can metabolize chemotherapeutic drugs
(Geller et al., 2017). Accordingly, intra-tumor bacteria may
contribute to resistance against chemotherapeutic drugs among
certain tumors. Since tumor sites possess elevated levels of H2O2
(50–100µM around a tumor site vs. 20 nM elsewhere in the
body) (De Garcia Lux et al., 2012), infection-control cascade
reactions based on endogenous H2O2 substrate availability
may play a role for this specific patient groups in treating
tumor-associated infections.
In short, cascade reactions have potential as a new infection
control strategy, but much work remains to be done to solve the
challenges listed above in order to make cascade reactions into
a real clinical addendum to the antimicrobial armamentarium of
modern medicine.
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